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Selenoproteins in parasites
Gustavo Salinas
Cátedra de Inmunología, Facultad de Química-Facultad de Ciencias, Universidad de la
República. Instituto de Higiene, Avda. A. Navarro 3051, Montevideo, CP 11600, Uruguay

Alexey V. Lobanov & Vadim N. Gladyshev
Department of Biochemistry, University of Nebraska–Lincoln, Lincoln, NE 68588-0664, USA

Summary: Parasites, which cause an enormous burden in the population of the third
world, are a diverse group of organisms, many of which are sensitive to oxidative
stress imposed by their hosts. In recent years, several selenoprotein families, some
with antioxidant properties, have been described and characterized in metazoan parasites. Glutathione peroxidase and thioredoxin glutathione reductase (TGR) appear to
be essential selenoproteins in flatworms (phylum Platyhelminthes). TGR is the single
enzyme that provides reducing equivalents to both thioredoxin and glutathione pathways, in contrast to hosts, which evolve parallel pathways. In roundworms (phylum
Nematoda), selenoproteins have recently been described, revealing species differences
in the Sec/Cys protein sets and the presence of an unusual SECIS element. Plasmodium sp, one of the most important protozoan parasites that affect humans, also decode Sec. The selenoprotein families encoded by Plasmodial genomes have neither
Sec nor Cys homologs in their hosts, raising the possibility that targeting their selenoproteomes may provide new treatment strategies.

Introduction
Although significant research efforts have been made to study selenoproteins
and selenocysteine insertion systems in humans and various model organisms, little has been reported in the literature regarding the utilization of selenium in eukaryotic parasitic organisms. This chapter focuses on the progress made in the characterization of selenoenzyme families in flatworms, the
recent advances in the synthesis and utilization of selenoproteins in roundworms and protozoan parasites, and discusses why selenoproteins of platyhelminths and plasmodia may represent interesting targets for chemo- or
immune-prophylaxis.
355

356

SALINAS, LOBANOV, & GLADYSHEV

IN

S E L E N I U M (2006)

Parasites: diverse organisms that face similar oxidative stress challenges
Parasites live at least part of their lifecycle inside another organism (the host),
which they exploit for their own survival and reproduction. This definition
includes different types of infectious agents (viruses, bacteria, fungi, protozoa, helminths). However, for historical reasons, the term is most often reserved for ‘protozoa’ and ‘helminths’ organisms. Indeed, parasitology was
identified as a separate research field during the exploration of the tropics and
the establishment of ‘tropical medicine’ [1]. Both ‘protozoa’ and ‘helminths’
also include free-living organisms, and neither ‘protozoa’ nor ‘helminths’ are
monophyletic; on the contrary, both groups are represented by highly divergent phyla. Nonetheless, this historical classification is not useless. These two
groups of parasites are very different: protozoan are unicellular protists, which
multiply quickly within the host, and are, in most cases, intracellular in habitat; in contrast, helminths are metazoan organisms with complex multicellular
organization (with nervous system and reproductive organs), which undergo
complex metamorphoses and migrations within the host. Table 1 presents the
main features of the major human parasitic infections.
In spite of the diversity of parasites, all face similar biological problems that
relate to their parasitic lifestyle. Among them, the neutralization of the effector
mechanisms deployed by the host immune system is of paramount importance.
Resident macrophages and inflammatory-site phagocytic leukocytes (mostly
neutrophils, but also monocytes and eosinophils, depending of the type of infection) are cells equipped to kill foreign organisms. They possess an oxidase
system located in their plasma membrane, which becomes activated upon certain stimuli, for example, by interaction of cell receptors with antibodies bound
to the foreign organism or with parasite molecular motifs (Figure la) [3]. Subsequently, ‘respiratory burst’ (increase in oxygen uptake not linked to respiration) takes place and produces superoxide anion and additional reactive oxygen species (ROS) [4]. Large amounts of nitric oxide (·NO) are also produced
by macrophages (and to a lesser extent by neutrophils) activated by a variety of
immunological stimuli, such as y-interferon and tumor necrosis factor. ·NO reacts with superoxide to produce peroxynitrite and other reactive nitrogen species (RNS) (Figure 1b) [5]. In addition, activated neutrophils and eosinophils
release myeloperoxidase and eosinophil peroxidase, respectively, that catalyze
the conversion of hydrogen peroxide and halides into hypohalous acids that are
powerful oxidants and can form further damaging species [4].
Collectively, ROS and RNS are powerful oxidants and nitrating species:
they can inactivate enzymes and initiate the process of lipid peroxidation and
nitration, which leads to radical chain reactions that further damage membranes, nucleic acids and proteins (Figure 1c). These processes (and an additional arsenal of the host effector cells, such as hydrolytic enzymes) may ultimately lead to killing parasitic organisms. Yet, well-adapted parasites cope
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Table 1. Major human parasites (Source: [2])
Protozoan parasitesb
Species (Disease)
Plasmodium sp
(Malariac)
Trypanosoma brucei
(sleeping sicknessd )
Trypanosoma cruzi
(Chagas diseasee)
Leishmania sp
(Leishmaniasisf)
Helminths parasitesg
Species/Disease
Schistosoma sp
(Schistosomiasis or bilharziag)
Onchocerca volvulus
(Onchocerciasis or river blindnessh)
Filariidae family
(Lymphatic filariasisi)
a DALYs:

Phylum
Apicomplexa

Death per year/DALYsa
1,124,000/42,280,000

Kinetoplastida

50,000/1,590,000

Kinetoplastida

13,000/649,000

Kinetoplastida

59,000/2,357,000

Phylum
Plathyhelminthes

Death per year/DALYs
15,000/1,760,000

Nematoda

0/987,000

Nematoda

0/5,644,000

Disability Adjusted Life Years (the number of healthy years of life lost due to premature death and disability).
b Protozoan parasites include many diverse phyla, among them Apicomplexa and
Kinetoplastida.
c Distribution: mainly confined to poorer tropical areas of Africa, Asia and Latin America.
More than 90% of malaria cases and the great majority of malaria deaths occur in tropical
Africa. Plasmodium falciparum is the main cause of severe clinical malaria and death.
d Distribution: 36 countries in sub-Saharan Africa
e Distribution: Latin America
f Distribution: Endemic in 88 countries on 4 continents. Two forms of the disease: cutaneous
(caused by Leishmania major), and visceral (caused by L. donovani)
g Helminth parasites are contained in three phyla: Nematoda (roundworms), Platyhelminthes
(flatworms) and Acantocephala (spiny-headed worms). Helminth infections are rarely fatal, but pose an enormous burden to human population in the tropics Distribution: endemic in 74 developing countries with more than 80% of infected people living in subSaharan Africa
h Distribution: 35 countries in total. 28 in tropical Africa, where 99% of infected people live.
Isolated foci in Latin America and Yemen.
i Distribution: Endemic in over 80 countries in Africa, Asia, South and Central America and
the Pacific Islands. Three species are of significance, Wuchereria bancrofti, Brugia malayi, and Brugia timori.
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with the oxidative stress imposed by the host’s immune response by a series
of cellular chemicals and antioxidant enzymes that directly neutralize ROS
and RNS (Figure Id), and constitute important model organisms to study antioxidant defense. Several antioxidant enzymes found in parasites belong to
selenoprotein families.
Glutathione peroxidase: the first selenoenzyme described in parasites
Glutathione peroxidase was the first selenoenzyme to be characterized from
a parasite. A cDNA from the platyhelminth Schistosoma mansoni encoding
a GPx with a TGA in-frame at the active site was cloned in the early 1990s
[6]. The protein encoded by this gene has biochemical properties similar to
mammalian phospholipid hydroperoxide glutathione peroxidase (PHGPx);
its activity being higher with phosphatidyl choline hydroperoxide and other
phospholipid hydroperoxides than with hydroperoxide substrates, such as
cumene hydroperoxide and hydrogen peroxide [7]. GPx and superoxide dismutase, another antioxidant enzyme, co-localize in the tegument and gut epithelium of adult worms, which are the exposed interfaces of the parasite towards the host [8]. Additional evidence suggests that antioxidant enzymes,
and GPx in particular, are vital for ROS neutralization and parasite survival
within the host. Indeed, expression of GPx is developmentally regulated,
Figure 1. Reactive oxygen and nitrogen species generated by the host immune response and antioxidant defenses, (a) Recognition of parasites by host leukocytes (such
as macrophages, neutrophils and eosinophils) occurs by pattern recognition receptors
(PRR) that bind to pathogen-associated molecular patterns (PAMPs), or through antibodies (Ig), and leads to activation of host immune cells. Upon activation, these cells
produce superoxide (·O2–) and nitric oxide (·NO) radicals. ·NO is produced in the cytosol (but can cross membranes) by inducible nitric oxide synthase (iNOS); ·O2– is produced by a multi-component, membrane-associated NADPH oxidase. Superoxide is
released towards the extracellular space in the case of non-phagocytosable parasites
(e.g., worms), or towards the phagosome (topologically equivalent to the extracellular space) in the case of intracellular parasites (e.g., protozoans). (b) ·NO and ·O2– react at diffusible controlled rate to produce peroxynitrite (ONOO–). Peroxynitrite can
react in one-electron oxidations (e.g., with transition metal centers), two electrons oxidations (of a given target), or with CO2, redirecting its reactivity. It also decomposes
spontaneously into other ROS and RNS such as ·OH and ·NO2. In addition, activated
neutrophils and eosinophils release myeloperoxidase and eosinophil peroxidases, respectively, which catalyze the conversion of hydrogen peroxide and halides into hypohalous acids. (c) Collectively, these products can inactivate enzymes, damage membranes and nucleic acids, and ultimately kill the parasitic organisms. (D) Parasites’
defenses include antioxidant enzymes that directly scavenge superoxide, decreasing
peroxynitrite formation (superoxide dismutases), and hydrogen and organic peroxide
reductases (GPx and TPx). Some TPx have also been shown to reduce peroxynitrite
catalytically. Repair mechanisms include methionine sulfoxide reductase, thioredoxin,
and sulfiredoxin among others. *R’H denotes a hydrocarbon chain, or alcohol (R’H =
ROH), or a thiol R’H = RSH)
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with the highest levels present in the adult worm [8], the stage most resistant to oxidative stress and immune elimination [9]. In addition, GPx expression is upregulated by hydrogen peroxide and xanthine/xanthine oxidase generated ROS [10].
Recently, a search for GPx in Expressed Sequence Tag databases (dbEST)
of platyhelminths identified a second GPx (GPx2) in S. mansoni and S. japonicum [11]. GPx2 also encodes a Sec residue at the active site and possesses an
N-terminal signal peptide, which targets this isoform to the extracellular compartment, suggesting that this secreted variant would be important for extracellular hydroperoxide removal, helping to protect the parasite in its immediate environment. In this study, a GPx1 ortholog whose 3’-untranslated region
revealed the presence of a SECIS element was also identified in Echinococcus
granulosus (another flatworm) transcriptome using the SECISearch algorithm
(Chapter 9 and http://genome.unl.edu/SECISearch.html) [12].
In contrast to platyhelminths, the corresponding Cys-containing enzymes
appear to occur in nematodes [13], as reviewed in [14]. Nevertheless, recent
data-mining of nematode dbEST revealed some exceptions (see below) [15].
Free-living nematode Caenorhabditis elegans has no Sec-containing GPx encoded in its genome [15].
GSH- and Trx-reduction pathways in platyhelminth parasites are
controlled by a single selenoenzyme
In most living organisms, there are two analogous and mutually supporting
enzymic systems that provide antioxidant defense to cells: the glutathione
(GSH) and the thioredoxin (Trx) systems (Figure 2) [16,17]. These systems
have overlapping yet distinct targets. GSH, due to its reactivity and intracellular concentration, is one of the most important cellular antioxidants, being
efficient in rescuing small disulfide molecules and in reacting directly with
ROS. The major function of Trx is to maintain cysteine residues in substrate
proteins in the reduced form. In addition to their direct function as antioxidants, GSH and Trx provide electrons to GPx and Trx peroxidase (TPx), respectively, which reduce hydrogen peroxide and organic hydroperoxides, and
to methionine sulfoxide reductase, which is also an important antioxidant repair enzyme. GSH and Trx are usually reduced by GSH and Trx reductases
(GR and TR), respectively, at the expense of NADPH oxidation.
Recent characterization of these systems in platyhelminth parasites has
shown that ‘conventional’ GR and TR are absent; instead, the GSH and Trx
systems are intermingled with the enzyme thioredoxin glutathione reductase
(TGR), which provides reducing equivalents to both pathways (Figure 2).
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This protein is a second selenoenzyme family that has been characterized in platyhelminth parasites (reviewed in [11]). TGR is an oxidoreductase
shown to possess TR, GR and Grx activities, achieving its broad substrate
specificity by a fusion between Grx and TR domains (Figure 2b); this domain
fusion was originally described in a mouse testis TGR [18].
Experimental and in silico data support the proposition that TGR is the single enzyme responsible for recycling both oxidized Trx and GSH in platyhelminth parasites. Treatment of S. mansoni adult worm extracts with auranofin, a known inhibitor of Sec-containing TRs, resulted in complete inhibition
of TR and GR activities [19]. In addition, TGR was the single protein isolated
from Taenia crassiceps (also a flatworm) extracts as a result of tracing GR
and TR activities [20]. Examination of EST databases from Schistosoma species, which covers more than 90% of the gene content of this organism [21],
revealed cDNAs encoding TGR, but not conventional TR or GR [11]. The
biochemical characterization of E. granulosus and T. crassiceps TGR indicated that the native enzyme shuttles electrons from NADPH to oxidized Trx
(TR activity), GSSG (GR activity) and glutathione-mixed disulfides (Grx activity). The stoichiometric inhibitory effect of auranofin on both GR and TR
activities of TGR indicates that the Sec-containing C-terminal redox center
participates in electron transfer to GSSG and oxidized Trx [20,22]. In addition, TR and Grx domains can function either in coupled reactions or independently. Conventional TRs neither bind GSH nor possess GR activity; thus,
the N-terminal Grx domain of TGR would reduce GSSG, accepting electrons
Figure 2. Linked thioredoxin-glutathione systems, (a) Comparison of thioredoxin,
glutathione and linked thioredoxin-glutathione systems. The glutathione system comprises (i) GR, GSH and Grx, whereas the thioredoxin system consists of (ii) TR and
Trx. In linked Trx-GSH systems (iii), TGR functionally replaces TR, GR and Grx, providing reducing equivalents to targets of both systems. In all systems, NADPH is the
upstream donor of reducing equivalents. (b) Components of the thioredoxin and glutathione systems. Redox centers of GR, TR, TGR, Grx and Trx are indicated, as well as
the FAD prosthetic group and the ligands NADPH and GSH. TR and TGR possess a
C-terminal extension missing in GR, which contains the C-terminal GCUG redox-active motif. TGR possesses an N-terminal Grx domain that is absent in TR and GR. The
Grx and Trx domains contain the CXXC redox center. Grx, unlike Trx, binds GSH. (c)
Schematic representation of electron flow in TGR. TGR, like GR and TR, is a homodimer, with monomers oriented in a head-to-tail manner. Electrons flow from NADPH to
FAD, to the CX4C redox center, to the C-terminal GCUG redox center of the second
subunit, to the CX2C redox center of the Grx domain of the first subunit, and to targets,
including GSSG (left scheme). Alternatively, electrons can flow, presumably directly,
from the GCUG redox center to Trx (right scheme). The model proposes a flexible
hinge, which connects the TR and Grx domains. This organization allows electrons to
flow to the ‘in built’ Grx domain or to Trx. Parts (a) and (b) in the figure reprinted with
modifications from [11] with copyright with permission from Elsevier.
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from the Sec-containing C-terminal redox center. The idea that the C-terminal
redox center donates electrons to the fused Grx domain implies that the Grx
domain of TGR would be linked to the TR domains by a flexible hinge to allow reduction of the oxidized Trx (Figure 2c). It is interesting to note that T.
crassiceps TGR showed a hysteretic behavior in enzymatic assays with GSSG
at high concentrations; this observation led the authors to propose a model
in which TGR would possess high and low affinity sites for glutathione [20].
Clearly, further biochemical characterization and structural data on this multifunctional enzyme are needed that will shed light on the mechanism of catalysis. In addition, molecular characterization of the corresponding gene could
also provide clues regarding the mechanism of generation of isoforms. Indeed, the analysis of TGR in E. granulosus revealed two trans-spliced cDNAs
derived from a single gene [22]. These variants code for mitochondrial (mt)
and cytosolic (c) TGRs, containing identical Grx and TrxR domains, but differing in their N-termini. These variants derive from alternative initiation of
transcription, followed by trans-splicing. Similarly, mtTGR and cTGR variants also derived from a single gene have been identified in S. mansoni [11].
Collectively, the results from platyhelminth studies strongly suggest that
TGR is the main pyridine-nucleotide thiol-disulfide oxidoreductase in these
organisms, in contrast to their hosts, where there is some redundancy of mechanisms for recycling oxidized Trx and GSH.
Very little has been published about these pathways in the other phylum of
helminth parasites (Nematoda), and to the best of our knowledge, nothing is
known about Sec/Cys-containing TR or TGR in parasitic nematodes. However, no single genome has yet been completed from metazoan parasites.
Selenoproteins of nematode parasites: old families, unusual SECIS
An in silico analysis of Caenorhabditis elegans and Caenorhabditis briggsae (free-living nematodes) genomes revealed that these organisms encode a
single a selenoprotein, TR [15], corroborating earlier experimental data [23].
However, no experimental studies have yet been performed with Selenoproteins from parasitic nematodes. Nevertheless, in a recent study [15], the existing nematode ESTs were searched for selenoprotein genes using SECISearch
and by screening for homologs of known Selenoproteins. These analysis identified selenoprotein homologs of selK, selT, selW, Sep15, selenophosphate
synthetase and GPx. Two interesting points were noted from these analyses.
First, various nematodes encode different selenoproteins, and the distribution
of selenoprotein families within this phylum is mosaic. Second, it was found
that all detected nematode selenoprotein genes contained an unusual form of
SECIS element, with G rather than a canonical A at the conserved position
preceding the quartet of non-Watson-Crick base pairs [15].
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Selenoproteins of protozoan parasites: waiting for surprises?
Very little is known about selenoproteins from protozoan parasites. Recently, the presence of tRNASec was described in several species of the phylum Apicomplexa [24] (Lobanov et al., submitted). Plasmodium falciparum,
which is the causative agent of malaria—the most overwhelming human parasitic infection, belongs to this phylum. The finding of tRNASec was consistent with the presence of putative EFsec and selenophosphate synthetase in P.
falciparum and other Plasmodia. In addition, tRNASec was observed in Toxoplasma, but not in Cryptosporidium parasites. Genome-wide searches for SECIS elements in the six Plasmodium genomes revealed four selenoprotein
genes. Interestingly, homology analyses of these proteins identified no hits
outside Apicomplexa, suggesting that these selenoproteins do not exist in the
apicomplexan hosts. These properties make the new selenoproteins attractive
targets for anti-malaria drug development.
The other reference in the literature to a parasite Sec-decoding protozoan
is the description of a Cys-containing selenophosphate synthetase from Leishmania major [25]. Leishmania belongs to trypanosomatidae family, which
also includes Trypanosoma brucei, and T. cruzi (Table 1), which are causative
agents of disabling and fatal diseases in the poorest rural population of the
third world [26]. Consistent with the finding of selenophosphate synthetase,
recent bioinformatics analyses revealed three selenoprotein genes in several
Trypanosoma genomes (Lobanov and Gladyshev, unpublished).
Finally, no single reference could be found in the literature regarding a
Sec-decoding amoebae, a traditional group of protozoa that include the parasitic amoebae of humans, Entamoebae histolytica.
Parasite selenoproteins: drug or vaccine candidates?
From a global perspective, the control of parasitic infections, which are a major cause of disability and mortality in many developing countries, remains as
one of the most important challenges for medicine in the 21st century [2]. Although there are safe and effective drugs to control some parasitic diseases,
parasites can develop resistance to drugs rendering them ineffective, as it has
been the case of certain antimalarial drugs [27]. Thus, effective vaccines and
new drugs against parasitic organisms are needed. The task ahead is enormous
considering that parasite and hosts are eukaryotic organisms; as yet, there is
not a single vaccine for a human parasitic infection. Whether selenoproteins
can be drug targets or generate immunity depends on premises that are not
necessarily different from those for any other target protein: the validity of a
drug target would rely on it being an essential protein, and sufficiently different from the host homolog(s) as to be selectively inhibited. Likewise, a good
vaccine candidate should generate an appropriate and selective immune response against the parasite, without inducing pathology to the host.
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In platyhelminths, TGR is an attractive pharmacological target because
of the lack of redundant mechanisms (i.e., TR and GR) to provide reducing
equivalents to essential enzymes. Inhibition of this enzyme could lead to impaired synthesis of DNA and antioxidant defenses, compromising parasite
survival. TGR may also be a good vaccine candidate, since it is a large protein
with a degree of identity to host enzymes below 60%. However, there are no
studies regarding TGR as an immunogen. Contrary to TGR, there are promising studies on the use of GPx as a vaccine candidate. Vaccination of mice (not
a natural host) against the platyhelminth S. mansoni with naked DNA constructs containing Sec-containing GPx showed significant levels of protection
compared to a control group [28]. In this context, it is important to emphasize not only the fact that GPx appears to be important at the host parasite interface, but also that platyhelminth lack catalase and rely exclusively on GSH
and Trx peroxidases for hydrogen peroxide removal.
In the case of protozoan parasites, further studies are needed to identify
and functionally characterize their selenoproteins. Nevertheless, it is highly
significant that the four selenoproteins identified in Plasmodium sp have
neither Sec nor Cys homologs in humans. Considering that Sec is usually
located at the redox-active sites of enzymes, the selenol- and thiol-based redox systems may play vital an important role in the survival of protozoan
parasites [29].
Finally, selenoproteins may be different to other proteins in one respect:
electrophilic drugs, such as gold or platinum compounds, or alkylating agents
that react preferentially with Sec over Cys may affect the parasite and the host
to a different extent, depending on the relative importance of selenoproteins
for the two organisms, and the presence/absence of Cys-containing enzymatic
back up systems.
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